Join the Botox group to help and get support from people like you.
Botox News
Botox Intervention Improves Facial Asymmetry After Nerve Damage
TUESDAY, March 18, 2025 – For patients with severe oral commissure droop from facial nerve damage undergoing surgery, botulinum toxin type A (BoNT-A) treatment helps to alleviate muscle...
Monthly News Roundup - October 2024
FDA Approves AbbVie’s Vyalev to Treat Advanced Parkinson Disease In October, the US Food and Drug Administration (FDA) approved Vyalev (foscarbidopa and foslevodopa) for the treatment of motor f...
BoNT-A Does Not Affect Gross Energy Cost of Walking in Cerebral Palsy
MONDAY, Aug. 12, 2024 – For children with cerebral palsy (CP), a single injection of botulinum neurotoxin A (BoNT-A) into the calf muscles does not affect the gross energy cost of walking, according...
Dose Requirements for Glabellar Botulinum Toxin Higher in High-Sun Climate
FRIDAY, July 19, 2024 – To achieve maximal paralysis, patients injected with glabellar botulinum toxin may have significantly higher dose requirements in a high sun-exposure environment, according...
CDC Reports Seven Cases of Illness After Possible Counterfeit Botox Injections
FRIDAY, July 12, 2024 – Seven patients with illness identified after presumed cosmetic botulinum neurotoxin (BoNT) product injection are described in a case report published in the July 11 issue of...
Fake Botox Shots Land 13 Women in Hospital
FRIDAY, July 12, 2024 – Seventeen women in nine states have fallen ill after getting fake Botox shots, with 13 of them landing in the hospital and one requiring a ventilator, a new report warns. In...
Targeted Diagnostic Botox Injections Can Identify Trigger Sites for Migraine
THURSDAY, May 9, 2024 – Diagnostic targeted Botox injections have high positive predictive value for migraine trigger site localization, according to a study published in the May issue of Plastic...
FDA Medwatch Alert: Counterfeit Versions of Botox Found in Multiple States
April 16, 2024 -- FDA is alerting health care professionals and consumers that unsafe counterfeit versions of Botox (botulinum toxin) have been found in multiple states and administered to consumers ...
FDA Approves Expanded Botox (onabotulinumtoxinA) Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity
NORTH CHICAGO, Ill., July 29, 2021 /PRNewswire/ – Allergan, an AbbVie (NYSE: ABBV) company, today announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion of Botox® ...
Botox (onabotulinumtoxinA) Receives FDA Approval for Pediatric Detrusor Overactivity Associated with a Neurologic Condition
NORTH CHICAGO, Ill., Feb. 10, 2021 /PRNewswire/ – Allergan, an AbbVie (NYSE: ABBV) company, today announced that the U.S. Food and Drug Administration (FDA) has approved Botox® for the treatment of ...
FDA Approves Expanded Botox (onabotulinumtoxinA) Label for the Treatment of Pediatric Patients with Spasticity
NORTH CHICAGO, Ill., July 9, 2020 /PRNewswire/ – Allergan, an AbbVie (NYSE: ABBV) company, today announced that the U.S. Food and Drug Administration (FDA) approved a supplemental Biologics License...
FDA Approves Botox (onabotulinumtoxinA) for Pediatric Patients with Lower Limb Spasticity, Excluding Spasticity Caused by Cerebral Palsy
DUBLIN, Oct. 24, 2019 /PRNewswire/ – Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) approved the company's supplemental Biologics License Application...
FDA Approves Botox (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
DUBLIN, June 21, 2019 /PRNewswire/ – Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) approved the company's supplemental biologics application (sBLA) for...
FDA Approves Botox (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity
DUBLIN, Jan. 22, 2016 /PRNewswire/ – Allergan plc (NYSE: AGN), a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has approved Botox...
FDA Approves Botox Cosmetic to Improve the Appearance of Crow’s Feet Lines
WEDNESDAY, September 11, 2013 – The U.S. Food and Drug Administration today approved a new use for Botox Cosmetic (onabotulinumtoxinA) for the temporary improvement in the appearance of moderate to...
Further information
Related condition support groups
Cervical Dystonia, Chronic Migraine, Facial Wrinkles, Hyperhidrosis, Migraine, Migraine Prevention, Migraine Prophylaxis, Overactive Bladder, Urinary Incontinence